Dr Martina Jones
Dr

Martina Jones

Email: 
Phone: 
+61 7 334 63178

Background

Operations Manager - National Biologics Facility

Deputy Director - ARC Training Centre for Biopharmaceutical Innovation

Research Areas: Discovery and engineering of antibodies for diagnostic or therapeutic uses

BScApp (Biotech) Honours Class I (1998) The University of Queensland

PhD (2008) The University of Queensland

Availability

Dr Martina Jones is:
Available for supervision

Fields of research

Agricultural biotechnology Medical biotechnology

Qualifications

  • Bachelor (Honours) of Applied Science, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Search Professor Martina Jones’s works on UQ eSpace

59 works between 2000 and 2024
All (59) Journal Article (42) Book Chapter (1) Conference Publication (14) Other Outputs (2)

41 - 59 of 59 works

2014

Journal Article

Nanocell targeting using engineered bispecific antibodies.

Taylor, Karin, Howard, Christopher B., Jones, Martina L., Sedliarou, Ilya, MacDiarmid, Jennifer, Brahmbhatt, Himanshu, Munro, Trent P. and Mahler, Stephen M. (2014). Nanocell targeting using engineered bispecific antibodies.. mAbs, 7 (1), 53-65. doi: 10.4161/19420862.2014.985952

Nanocell targeting using engineered bispecific antibodies.

2014

Journal Article

Monoclonal antibody-targeted polymeric nanoparticles for cancer therapy - future prospects

Goodall, Stephen, Jones, Martina L. and Mahler, Stephen (2014). Monoclonal antibody-targeted polymeric nanoparticles for cancer therapy - future prospects. Journal of Chemical Technology and Biotechnology, 90 (7), 1169-1176. doi: 10.1002/jctb.4555

Monoclonal antibody-targeted polymeric nanoparticles for cancer therapy - future prospects

2014

Journal Article

Development of a protein nanoparticle platform for targeting EGFR expressing cancer cells

Buecheler, Jakob W., Howard, Christopher B., de Bakker, Christopher J., Goodall, Stephen, Jones, Martina L, Win, Thinzar, Peng, Tao, Tan, Cher Heng, Chopra, Akhil, Mahler, Stephen M and Lim, Sierin (2014). Development of a protein nanoparticle platform for targeting EGFR expressing cancer cells. Journal of Chemical Technology and Biotechnology, 90 (7), 1230-1236. doi: 10.1002/jctb.4545

Development of a protein nanoparticle platform for targeting EGFR expressing cancer cells

2014

Journal Article

An EGFR targeting nanoparticle self assembled from a thermoresponsive polymer

Goodall, Stephen, Howard, Christopher B., Jones, Martina L., Munro,Trent, Jia, Zhongfan, Monteiro, Michael J and Mahler, Stephen (2014). An EGFR targeting nanoparticle self assembled from a thermoresponsive polymer. Journal of Chemical Technology and Biotechnology, 90 (7), 1222-1229. doi: 10.1002/jctb.4509

An EGFR targeting nanoparticle self assembled from a thermoresponsive polymer

2014

Journal Article

Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2

Leow, Chiuan Herng, Jones, Martina, Cheng, Qin, Mahler, Strphen and McCarthy, James (2014). Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2. Malaria Journal, 13 (1) 277. doi: 10.1186/1475-2875-13-277

Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2

2014

Conference Publication

The Monoclonal Antibody 3C12C, Targeting CD83 Is a T Cell Sparing, Potential New Immunosuppressive Agent

Hart, D, Verma, N., Seldon, T, Sheng, Y., Pryor, R., Palkova, A., Findova, M., Jones, M., Munro, T., Mahler, S., Braet, K., Barnard, R., Marks, J., Coley, A., Fan, F., Zhou, Y., Vu, P, Lo, K., Shahin, K., Elgundi, Z., Silveira, P., Fromm, P., Clark, G., Larsen, S., Bradstock, K. and Munster, D. (2014). The Monoclonal Antibody 3C12C, Targeting CD83 Is a T Cell Sparing, Potential New Immunosuppressive Agent. 2014 World Transplant Congress, San Francicso Ca, 26 - 31 July 2014. Malden, MA United States: Wiley-Blackwell Publishing, Inc.. doi: 10.1111/ajt.12888

The Monoclonal Antibody 3C12C, Targeting CD83 Is a T Cell Sparing, Potential New Immunosuppressive Agent

2013

Other Outputs

Anti-CD83 antibodies and use thereof

Seldon, T. A., Munster, D. J., Hart, D. N., Jones, M. L., Munro, T. P., Mahler, S. M., Zhou, Y. and Marks, D. (2013). Anti-CD83 antibodies and use thereof.

Anti-CD83 antibodies and use thereof

2011

Journal Article

Clonal selection of high producing, stably transfected HEK293 cell lines utilizing modified, high-throughput FACS screening

Song, Michael, Raphaelli, Kristin, Jones, Martina L., Aliabadi-Zadeh, Khosrow, Leung, Kar Man, Crowley, David, Hughes, Benjamin, Mahler, Stephen, Gray, Peter P., Huang, Edwin P. and Chin, David Y. (2011). Clonal selection of high producing, stably transfected HEK293 cell lines utilizing modified, high-throughput FACS screening. Journal of Chemical Technology and Biotechnology, 86 (7), 935-941. doi: 10.1002/jctb.2618

Clonal selection of high producing, stably transfected HEK293 cell lines utilizing modified, high-throughput FACS screening

2011

Journal Article

Improved protein-A separation of Vh3 Fab from Fc after papain digestion of antibodies

Seldon, Therese A., Hughes, Karen E., Munster, David J., Chin, David Y. and Jones, Martina L. (2011). Improved protein-A separation of Vh3 Fab from Fc after papain digestion of antibodies. Journal of Biomolecular Techniques, 22 (2), 50-52.

Improved protein-A separation of Vh3 Fab from Fc after papain digestion of antibodies

2010

Journal Article

A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies

Jones, Martina L., Seldon, Therese, Smede, Matthew, Linville, Ashleigh, Chin, David Y., Barnard, Ross, Mahler, Stephen M., Munster, David, Hart, Derek, Gray, Peter P. and Munro, Trent P. (2010). A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies. Journal of Immunological Methods, 354 (1-2), 85-90. doi: 10.1016/j.jim.2010.02.001

A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies

2009

Conference Publication

Developing a Therapeutic Anti - Dendritic Cell Antibody to Prevent Graft Versus Host Disease

Hart, D, Seldon, T, Jones, M, Sheng, Y, Palkova, A, Cullup, H, Munro, T, Sinfield, L, Rice, AM, Wilson, J, Gray, P, Barnard, R, Mahler, S and Munster, D (2009). Developing a Therapeutic Anti - Dendritic Cell Antibody to Prevent Graft Versus Host Disease. 51st Annual Meeting of the American Society of Hematology, New Orleans LA, 5-8 December 2009. Washington, D.C.: American Society of Hematology.

Developing a Therapeutic Anti - Dendritic Cell Antibody to Prevent Graft Versus Host Disease

2008

Other Outputs

Engineered antibodies. Production and application of chimeric and single-chain antibodies as positive controls in the diagnosis of infectious diseases by ELISA.

Jones, Martina (2008). Engineered antibodies. Production and application of chimeric and single-chain antibodies as positive controls in the diagnosis of infectious diseases by ELISA.. PhD Thesis, School of Molecular and Microbial Sciences, The University of Queensland. doi: 10.14264/156737

Engineered antibodies. Production and application of chimeric and single-chain antibodies as positive controls in the diagnosis of infectious diseases by ELISA.

2007

Journal Article

Use of chimeric antibodies as positive controls in an enzyme-linked immunosorbent assay for diagnosis of scrub typhus (infection by orientia tsutsugamushi)

Jones, Martina L. and Barnard, Ross (2007). Use of chimeric antibodies as positive controls in an enzyme-linked immunosorbent assay for diagnosis of scrub typhus (infection by orientia tsutsugamushi). Clinical and Vaccine Immunology, 14 (10), 1307-1310. doi: 10.1128/CVI.00114-07

Use of chimeric antibodies as positive controls in an enzyme-linked immunosorbent assay for diagnosis of scrub typhus (infection by orientia tsutsugamushi)

2005

Journal Article

Chimerization of multiple antibody classes using splice overlap extension PCR

Jones, M. L. and Barnard, R. T. (2005). Chimerization of multiple antibody classes using splice overlap extension PCR. Biotechniques, 38 (2), 181-182. doi: 10.2144/05382BM01

Chimerization of multiple antibody classes using splice overlap extension PCR

2003

Conference Publication

Dietary interactions influence the effects of bovine folate-binding protein on the bioavailability of tetrahydrofolates in rats

Jones, ML, Treloar, T and Nixon, PF (2003). Dietary interactions influence the effects of bovine folate-binding protein on the bioavailability of tetrahydrofolates in rats. USA: American Society for Nutritional Sciences. doi: 10.1093/jn/133.2.489

Dietary interactions influence the effects of bovine folate-binding protein on the bioavailability of tetrahydrofolates in rats

2002

Journal Article

Tetrahydrofolates are greatly stabilized by binding to bovine milk folate-binding protein

Jones, M. L. and Nixon, P. F. (2002). Tetrahydrofolates are greatly stabilized by binding to bovine milk folate-binding protein. Journal of Nutrition, 132 (9), 2690-2694. doi: 10.1093/jn/132.9.2690

Tetrahydrofolates are greatly stabilized by binding to bovine milk folate-binding protein

2001

Conference Publication

Availability of folate bound to folate-binding protein: Environmental effects

Jones, M. L., Treloar, W. and Nixon, P. F. (2001). Availability of folate bound to folate-binding protein: Environmental effects. 2nd Dairy Industry Association of Australia World Series of Dairy Science Conference, Australia, 2001. Melbourne: Dairy Industry Association of Australia.

Availability of folate bound to folate-binding protein: Environmental effects

2000

Conference Publication

Stability of labile folate is enhanced by binding milk folate-binding protein

Hutchinson, M. L., Jones, M. and Nixon, P. F. (2000). Stability of labile folate is enhanced by binding milk folate-binding protein. Dairy Ingredient Science 2000 Conference, Melbourne, Australia, 28-30 Jun, 2000. Melbourne, Australia: Dairy Industry Association of Australia.

Stability of labile folate is enhanced by binding milk folate-binding protein

2000

Conference Publication

Milk folate-binding protein; ligand-binding properties and polymerization properties

Jones, MD, Hutchinson, ML and Nixon, PF (2000). Milk folate-binding protein; ligand-binding properties and polymerization properties. Dairy Ingredient Science 2000 Conference, Melbourne, Australia, 2000. Melbourne,VIC: Dairy Industry Association of Australia.

Milk folate-binding protein; ligand-binding properties and polymerization properties

Current funding

  • 2023 - 2025
    An accessible chronic pain therapeutic target in peripheral sensory nerves (NHMRC Ideas Grant led by University of Melbourne)
    University of Melbourne
    Open grant
  • 2023 - 2028
    Development of reagents for blood product safety
    Australian Red Cross Society
    Open grant
  • 2016 - 2029
    Special Access m102.4 Antibody
    Queensland Health
    Open grant

Past funding

  • 2020 - 2021
    Manufacture of a monoclonal antibody for use as a single-step immunoselection of blood dendritic cells aiding in the development of a patient-specific cancer vaccine
    Queensland Biomedical Voucher Program
    Open grant
  • 2019 - 2020
    Manufacture of two anti-midkine antibodies for potential cancer and inflammatory disease therapy'
    Department of State Development QLD
    Open grant
  • 2019
    Cyto-Mine to accelerate Cell Line Development for Vaccines and Biopharmaceuticals
    UQ Major Equipment and Infrastructure
    Open grant
  • 2017 - 2018
    Affinity Maturation of Anti-Lipopolysaccharide Antibody
    Innovation Connections
    Open grant
  • 2017 - 2023
    ARC Training Centre for Biopharmaceutical Innovation
    ARC Industrial Transformation Training Centres
    Open grant
  • 2017
    Platform technology for the discovery of antibodies to membrane proteins using cell-free expression
    UQ Early Career Researcher
    Open grant
  • 2016 - 2018
    ZZ Biotech Research Development
    ZZ Biotech Pty Ltd
    Open grant
  • 2014 - 2023
    The National Biologics Facility - NCRIS 2013/2015/2016-17/2017-18/2018-19/2019-2023 (administered by Therapeutic Innovation Australia (TIA))
    Therapeutic Innovation Australia Limited
    Open grant
  • 2013 - 2014
    The Manufacture of a Recombinant Antibody
    UniQuest Pty Ltd
    Open grant
  • 2013 - 2015
    Safety assessment of anti-hendra virus antibody in humans
    Queensland Health
    Open grant
  • 2012 - 2015
    Targeting the delivery of cytotoxic agents to tumour cells using novel minicells as drug delivery vehicles and engineered, bispecific antibodies
    ARC Linkage Projects
    Open grant

Availability

Dr Martina Jones is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

For media enquiries about Dr Martina Jones's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au